Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 183 publications
Editor's Note: Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 13, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
Journal: The New England journal of medicine
Published: June 01, 2026
Promising New Platforms and Targets in the Management of Gastroesophageal Cancers.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 07, 2026
Impact of UGT1A1*28 polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial.
Journal: Future oncology (London, England)
Published: May 04, 2026
Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 23, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma.
Journal: Journal for immunotherapy of cancer
Published: January 12, 2026
Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies.
Journal: ESMO open
Published: December 17, 2025
The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 01, 2025
The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.
Journal: The Lancet. Oncology
Published: September 25, 2025
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial.
Journal: Nature communications
Published: September 19, 2025
Neoadjuvant stereotactic body vs conventionally fractionated radiation therapy for borderline resectable and locally advanced pancreatic cancer: a propensity score-matched analysis.
Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: September 03, 2025
Last Updated: 09/26/2026